Our data spatially demonstrate that having intact TGF-β signaling in PTs promotes an adaptive response to CKD and show that TβRII deletion in the PT worsens mitochondrial injury and Th1 immune response in CKD. This evidence concerns the gene TGFBR2 and chronic kidney disease.